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http:WHAT THIS PAPER ADDS
The ipsilateral ECA can potentially provide an important collateral pathway for retinal and cerebral blood ﬂow in
the presence of occlusion or severe stenosis of the ICA, especially in patients with an incomplete circle of Willis.
Progression of disease in the ECA due to treatment of a stenotic ICA lesion during CAS or CEA could jeopardize
collateral blood ﬂow. Limitation of ECA patency might be a further argument against carotid artery stenting
when a progression of stenosis is observed following CAS. We therefore studied the ﬂow velocities in the ECA
following CAS and CEA.Objective: To study the changes in peak systolic velocities of the ipsilateral external carotid artery (ECA) following
carotid revascularization.
Methods: All patients randomized to carotid artery stenting (CAS) or carotid endarterectomy (CEA) in the
International Carotid Stenting Study (ICSS; ISRCTN25337470) in our center were included. Peak systolic velocities
(PSV) were assessed with duplex ultrasound (DUS) at baseline, at 30 days, and at 12 and 24 months after
treatment. Our primary outcome measure was the change in blood ﬂow velocities in the ECA (DPSVECA).
Secondary outcome measure was the prevalence of post interventional ECA occlusion.
Results: Of 270 patients enrolled in ICSS at our center, 224 patients (mean age, 68.8 years; 154 males) were
included in the present study (116 CAS, 108 CEA). Baseline PSV in the ipsilateral ECA was similar between the
groups. Following CAS, PSV gradually increased during follow-up, whereas PSV remained relatively stable after
CEA; mean difference of PSV between CAS and CEA: 23 cm/s (95% CI, e5 to 52), 58 cm/s (95% CI, 27e89), and
69 cm/s (95% CI, 31e107) at 30 days, 12 months, and 24 months. One new ECA occlusion occurred after CAS and
two after CEA.
Conclusion: Blood ﬂow velocities in the ipsilateral ECA increase signiﬁcantly after CAS but not after CEA.
However, this does not lead to a higher rate of ECA occlusion in the ﬁrst 2 years after revascularization. We
conclude that CAS is not inferior to CEA in preserving the ECA as a possible potential collateral pathway for
cerebral blood supply within 2 years following revascularization.
Crown Copyright  2013 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All rights
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Carotid artery stenting (CAS) has been considered as an
alternative to carotid endarterectomy (CEA) in the treat-
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//dx.doi.org/10.1016/j.ejvs.2013.07.00230-day outcome regarding stroke and death rates following
CAS compared with CEA,2 recurrent stenosis and its man-
agement are reported disadvantages of stenting. Other
possible disadvantages might be the covering of the oriﬁce
of the external carotid artery (ECA), or leaving the stenosis
at the ECA origin untreated with stenting compared with
optional ECA endarterectomy during CEA.
In many CAS cases, the stent is placed from the internal
carotid artery (ICA), extending into the common carotid ar-
tery (CCA), thereby covering the origin of the ECA. Progres-
sion of disease in the ECA due to treatment of a stenotic ICA
lesion during CAS or CEA could, if the ICA subsequently
412 B.L. Reichmann et al.occludes, jeopardize collateral blood ﬂow, especially in pa-
tients with an incomplete circle of Willis.3e6 In contrast to
the ICA, evaluation of development of ECA stenosis has been
reported rarely.7e9 As far as we know, only two (non-
randomized) studies have been published so far concerning
the effect of carotid stent placement on the ipsilateral ECA
immediately after the procedure and during follow-up.8,10
These studies report stenosis rates of the ECA ranging from
38% to 65% after 2 years of follow-up. The fate of the ipsi-
lateral ECA following CEA has been investigated with7 and
without9 additional endarterectomy of the ECA. Restenosis
rates with blind endarterectomy of the ECA were reported as
40% after 2 years of follow-up while only 7% developed ECA
stenosis after ICA endarterectomy without endarterectomy
of the ECA.
In a previous study concerning ﬂow velocities in the ICA
in a comparable cohort, we observed increased peak sys-
tolic velocities in the ICA following stenting compared with
CEA.11 In order to analyze whether this relatively larger
increase in ﬂow velocities following CAS as opposed to ﬂow
velocity change after CEA also occurs in the ECA, we
analyzed the changes in blood ﬂow velocities in the ipsi-
and contralateral ECA following either CAS or CEA within a
cohort of the randomized controlled International Carotid
Stenting Study (ICSS) during 2 years of follow-up.METHODS
Patients
All patients in the present study were participants in the
International Carotid Stenting Study (ICSS; ISRCTN25337470)
at the University Medical Center Utrecht, the Netherlands,
enrolled between September 2003 and October 2008. ICSS is
an international, multicenter, randomized, controlled, open,
clinical trial, comparing the risks, beneﬁts, and cost-
effectiveness of CAS and CEA in patients with a recently
symptomatic ICA stenosis 50%. Patient criteria, randomi-
zation, and the results of an interim safety analysis have
been described elsewhere.2,12 Baseline demographic, clinical,
and carotid imaging data were collected as part of ICSS.
Randomization in ICSS was stratiﬁed by center, with mini-
mization for sex, age, contralateral occlusion, and side of the
randomized artery. The degree of carotid stenosis was
assessed by duplex ultrasound scanning (DUS) in all patients
and conﬁrmed with either CT angiography (CTA) or MR
angiography (MRA) prior to enrolment.Carotid endarterectomy procedure
A vascular surgeon who had been approved by the Cre-
dentials Committee performed CEA. Shunts or patches were
selectively used as required by the operating surgeon. In
our vascular center, endarterectomy of the ICA was per-
formed using a longitudinal arteriotomy with eversion
endarterectomy of the ECA. Premedication (aspirin,
statin, dipyridamol) was started prior to the procedure at
the outpatient clinic and continued indeﬁnitely during
follow-up.Carotid angioplasty and stenting procedure
A designated interventionalist performed CAS with percuta-
neous transluminal interventional techniques using femoral
access. The type of stent and use of a cerebral protection
device (CPD) were applied at the discretion of the inter-
ventionalist. Premedication (combination of aspirin, clopi-
dogrel, and statin) was prescribed at a minimum 3 days prior
to stenting to cover the period of stenting, and clopidogrel
was prescribed for a minimum of 12 weeks afterwards.
Aspirin and statin were continued indeﬁnitely.Duplex ultrasound scanning
DUS of the ipsilateral and contralateral carotid arteries was
performed in a single vascular laboratory before randomi-
zation and at 1 month and 1 and 2 years after treatment
(HP/Agilent, Sonos 2500 or 4500, Andover, MA, USA). At
each time point the ipsilateral and contralateral PSV of ICA
(PSVICA), ECA (PSVECA), and CCA (PSVCCA) were recorded. The
DUS criteria for the ICA used in our vascular laboratory are
based on the modiﬁed strandness criteria (mild stenosis,
<50% [PSV < 125 cm/s]; moderate stenosis, 50e69%
[PSV > 125e230 cm/s], signiﬁcant stenosis, 70e99%
[PSV > 230 cm/s] and occlusion).13Outcome measures
Our primary outcome measure was the pattern of changes
in blood ﬂow velocities reﬂected by the change of PSV in
the ECA following carotid revascularization. Our secondary
outcome measure was the progression of ECA stenosis to
occlusion.Statistical analysis
We compared mean differences (MD) between treatment
groups in the changes in PSV with a t test for equality of
means. Cox regression analysis was performed to calculate
hazard ratios. Effect estimates are accompanied by corre-
sponding 95% conﬁdence intervals (CI). A p value <.05 was
considered statistically signiﬁcant for all analyses.
RESULTS
Patients and follow-up
A total of 270 patients were enrolled in ICSS at our center,
of whom 136 were randomized to CAS and 134 to CEA.
Forty-six patients were excluded from the present study due
to the following reasons: incomplete pre-interventional DUS
(n ¼ 32); ICA occlusion prior to revascularization (n ¼ 7);
death between randomization and actual revascularization
(n ¼ 3); or no intervention performed because of recent
myocardial infarction (n ¼ 4). Therefore, in total 116 CAS
and 108 CEA patients remained for analysis in the present
substudy. There were no signiﬁcant differences in baseline
characteristics between the two groups (Table 1). During
follow-up all 224 patients completed follow-up at 30 days. A
ﬂow chart of the included patients during follow-up is
shown in Fig. 1.
Table 1. Baseline characteristics.
Patient characteristics CEA CAS
n 108 116
Male 74 (68.5) 80 (69.0)
Age (range,
years)
69.1 (44e88) 68.6 (47e84)
Side treated Left 49 (45.4) 55 (47.4)
Symptoms at
presentation
Retinal infarction 2 (1.9) 4 (3.5)
Transient ischemic
attack
44 (40.7) 49 (42.2)
Amaurosis fugax 34 (31.5) 28 (24.1)
Ischemic stroke 28 (25.9) 35 (30.2)
Ipsilateral
degree of
stenosis
50e69% 11 (10.2) 10 (8.6)
70e99% 97 (89.8) 106 (91.4)
Contralateral
degree of
stenosis
0e49% 69 (63.9) 68 (58.6)
50e69% 11 (10.2) 17 (14.7)
70e99% 19 (17.6) 26 (22.4)
Occlusion 9 (8.3) 5 (4.3)
Diabetes mellitus 21 (19.4) 21 (18.1)
Treated hypertension 70 (64.8) 77 (66.4)
Treated hyperlipidemia 80 (74.1) 79 (68.1)
Myocardial infarction 20 (18.5) 17 (14.7)
Atrial ﬁbrillation 6 (5.6) 5 (4.3)
Previous coronary artery bypass
graft
17 (15.7) 12 (10.3)
(History of) Smoking 91 (84.3) 98 (84.5)
Note. Results are n and (%), unless indicated otherwise.
CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy.
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Prior to intervention the PSVECA in both groups was similar,
161.7 cm/s (CAS) versus 150.9 cm/s (CEA). During a 2-year
follow-up, ipsilateral PSVECA increased following CAS, while
the PSVECA following CEA remained relatively unchangedFigure 1. Flow-char(Table 2; Fig. 2). The differences in PSVECA between CAS and
CEA were statistically signiﬁcant at all follow-up points. On
the contralateral (non-treated) side the pre-interventional
PSV was similar, 141.1 cm/s (CAS) versus 148.2 cm/s
(CEA), and remained similar comparing CAS with CEA during
follow-up. There was a minor progression of PSVECA in both
the ipsilateral and contralateral arteries during follow-up in
both treatment groups (Table 2).
When we adjusted for baseline differences in the ipsi-
lateral PSVECA between CAS and CEA, there still was a sig-
niﬁcant increase in DPSV following CAS after 1 and 2 years
of follow-up (Table 3).
The prevalence of patients with an ipsilateral PSVECA
exceeding 125 cm/s following both procedures during follow-
up is shown in Fig. 3. There was no signiﬁcant difference
between both procedures (HR 1.31 [95% CI, 0.96e1.79]).
The prevalence of patients with PSVECA >125 cm/s in the
above paragraph includes patients with ECA stenosis prior
to treatment. To accurately analyze the occurrence of truly
new cases with PSVECA >125 cm/s and evaluate the effect
of the individual treatment on the progression of PSVECA,
these patients with a pre-procedural PSVECA >125 cm/s
should be excluded. After exclusion, 110 patients remained
for analysis (56 CAS and 54 CEA). The prevalence of new
cases with a PSVECA exceeding >125 cm/s in the ipsilateral
ECA also did not differ between the two groups (HR 1.16
[95% CI, 0.71e1.89]). When the stent was placed in the
distal CCA extending in the ICA and thereby covering the
oriﬁce of the ECA (in 78% of our cases), this did not affect
ECA ﬂow velocities compared with stents placed selectively
in the ICA.
Increased PSVECA after treatment was only in part related
to increasing PSVICA (Table 4); after 2 years of follow-up
following CAS, we observed a PSV exceeding 125 cm/s int of follow-up.
Table 2. Mean PSVECA (cm/s): baseline ipsi-/contralateral, CAS versus CEA.
Randomization n Mean (SD) Mean diff. (CAS  CEA) 95% CI
Ipsilateral side
Preintervention CAS 116 161.7 (94.1) 10.8 (13.5 to 35.1)
CEA 108 150.9 (89.9)
30-Day follow-up CAS 116 175.9 (114.3) 34.2 (7.4 to 61.1)*
CEA 108 141.7 (86.6)
1-Year follow-up CAS 111 206.7 (122.9) 60.3 (32.1 to 88.4)*
CEA 102 146.4 (79.1)
2-Year follow-up CAS 107 216.4 (142.5) 71.4 (38.2 to 104.6)*
CEA 95 145.0 (85.1)
Contralateral side
Preintervention CAS 116 141.1 (86.9) 7.1 (29.7 to 15.5)
CEA 108 148.2 (84.6)
30-Day follow-up CAS 116 142.6 (90.2) 0.6 (22.4 to 21.2)
CEA 103 143.2 (70.6)
1-Year follow-up CAS 111 146.9 (90.0) 8.3 (31.8 to 15.1)
CEA 101 155.2 (82.5)
2-Year follow-up CAS 107 154.0 (101) 6.1 (31.3 to 19.2)
CEA 95 160.1 (77.8)
Note. CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy; ECA ¼ external carotid artery; PSV ¼ peak systolic velocity.*p < .05.
414 B.L. Reichmann et al.both the ICA and the ECA in 27 of 107 (25%) patients.
Following CEA this was observed in 12 of 95 (13%) of pa-
tients (p ¼ .02).
The sample size of our study was too small to accurately
analyze differences in ﬂow velocities between different
stent types. Analysis could also not provide us with signif-
icant differences in ﬂow velocities between open versus
closed cell stent types, but we did observe a trend of higher
ﬂow velocities in the ECA in stents with closed cell design.Occlusion
The occlusion rate was similar following both procedures
(CAS vs. CEA); 0 versus 1 (0.9%) at 30 days, 0 versus 2 (1.9%),
and 1 (0.9%) versus 2 (1.9%) after 1 and 2 years of follow-up.Figure 2. PSVECA ipsi-/contralateral, carotid artery stenting versus
CEA ¼ carotid endarterectomy; ECA ¼ external carotid artery; PSV ¼DISCUSSION
In our current analysis a signiﬁcant increase in blood ﬂow
velocities in the ECA was observed in patients who had
been treated by CAS as opposed to patients treated by CEA.
This increase in PSV over time, however, did not lead to a
higher rate of ECA occlusion, even in patients with the stent
covering the oriﬁce of the ECA. Despite apparent progres-
sive ECA stenosis based on DUS velocities, none of the
patients with ECA stenosis after treatment had ipsilateral
neurological sequelae.
Development of increased PSV in the ECA was accom-
panied with increased PSV in the ipsilateral ICA in only one-
quarter of patients. This means that PSV-ECA increase is not
purely the result of higher in stent velocities caused by the
stent itself.Whether or not, and to what extent, the ECA hascarotid endarterectomy. Note. CAS ¼ carotid artery stenting;
peak systolic velocity.
Table 3. Mean PSVECA (cm/s): baseline ipsi-/contralateral, CAS versus CEA.
Randomization n DPSV(mean) Mean diff. (CAS  CEA) 95% CI
Ipsilateral side
Preintervention CAS 116 N/A N/A N/A
CEA 108 N/A
30-Day follow-up CAS 116 14.2 23.4 (4.7 to 51.5)
CEA 108 9.2
1-Year follow-up CAS 111 52.4 58.5 (27.4 to 89.2)*
CEA 102 5.9
2-Year follow-up CAS 107 63.2 69.2 (31.8 to 107.5)*
CEA 95 6.4
Contralateral side
Preintervention CAS 116 N/A N/A N/A
CEA 108 N/A
30-Day follow-up CAS 116 1.5 7.7 (6.3 to 21.6)
CEA 103 6.2
1-Year follow-up CAS 111 6.5 2.1 (17.3 to 21.5)
CEA 101 4.4
2-Year follow-up CAS 107 18.6 10.5 (8.9 to 29.8)
CEA 95 8.1
Note. DPSV(mean) reﬂects the difference between PSVECA preprocedurally and PSVECA at time of follow-up. CAS ¼ carotid artery stenting;
CEA ¼ carotid endarterectomy; ECA ¼ external carotid artery; PSV ¼ peak systolic velocity.*p < .001.
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clear. However, a widely patent ECA may provide important
collateral cerebral blood ﬂow, especially in the presence of
occlusion or severe stenosis of the ICA.6,14,15 Even in pa-
tients with a limited collateral supply, focal brain regionsFigure 3. KaplaneMeier estimates for prevalence of ipsilateral PSVECA
>125 cm/s, carotid artery stenting versus carotid endarterectomy
(n¼ 224).Note.Time schedule, baselinee 30dayse 1 yeare 2 years.
p¼ .07; CAS, 39.7% (baseline)e 44.0%e 58.3%e 69.4%; CEA, 26.8%
(baseline) e 28.7% e 43.8% e 60.9%. Standard error: CAS, 4.5% e
4.6%e 4.6%e 4.4%; CEA, 4.3%e 4.6%e 4.8%e 4.9%. CAS¼ carotid
artery stenting; CEA ¼ carotid endarterectomy; ECA ¼ external
carotid artery; PSV ¼ peak systolic velocity.might strongly depend on the contribution to cerebral
perfusion of the ipsilateral ECA.5 Preserving this ECA
pathway might therefore be very important in patients
undergoing carotid revascularization, especially in patients
who develop restenosis of the ICA following carotid revas-
cularization. The ECA could then provide a collateral route
for retinal and cerebral perfusion. The exact clinical impact
of stenosis of the ECA, however, remains unclear.16,17 There
have however been case reports that describe plaque in the
ECA which served as a source of emboli into the internal
carotid circulation.18
To our knowledge no other randomized study of stenting
versus endarterectomy has analyzed the fate of the ECA
after carotid revascularization. Our current results are in
harmony with previous non-randomized studies on ECA
patency following CAS showing a higher rate of ipsilateral
ECA stenosis than the contralateral side, along with a low
ECA occlusion rate.10 There are limited data on the inﬂu-
ence of stent placement from the CCA extending into the
ICA (thereby covering the ECA oriﬁce) on ECA patency.
However, in contrast to our previous retrospective obser-
vation, progression of stenotic disease in patients with the
ECA oriﬁce covered by stenting was not more pronounced
in our current analysis.10 Concern about the effects of ECA
coverage should not deter stent extension from the ICA to
the CCA during CAS.19 In another study, only two new ECA
occlusions occurred after CAS and neither of the ECA oc-
clusions had neurological sequelae. The ﬁndings from this
retrospective analysis are in line with our prospective,
randomized observations.
We observed that after stenting, ECA ﬂow velocities in-
crease, whereas ﬂow velocities following CEA remain rela-
tively stable. We could not ﬁnd an obvious explanation for
this observation but theoretically plaque may theoretically
protrude through the stent pores into the stent and oriﬁce
of the ECA following stent placement and expand over time.
Table 4. Number of patient with PSVECA and PSVICA exceeding 125 cm/s during follow-up.
30 Days 1 Year 2 Years
CAS
PSVICA  125 cm/s (n) 15/116 (13%) 31/111 (28%) 38/107 (36%)
PSVECA  125 cm/s (n) 60/116 (52%) 77/111 (69%) 79/107 (74%)
Both  125 cm/s (n) 12/116 (10%) 26/111 (23%) 27/107 (25%)
CEA
PSVICA  125 cm/s (n) 11/108 (10%) 13/102 (13%) 17/95 (18%)
PSVECA  125 cm/s (n) 45/108 (42%) 61/102 (61%) 56/95 (59%)
Both  125 cm/s (n) 8/108 (7%) 11/102 (11%) 12/95 (13%)
Note. CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy; ECA ¼ external carotid artery; ICA ¼ internal carotid artery;
PSV ¼ peak systolic velocity.
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origin of the ECA following CAS could cause a reduction of
the luminal diameter and could therefore cause increased
ﬂow velocities. Another explanation could be that changed
hemodynamics caused by stent placement in the ICA may
lead to increases in ﬂow velocities in the ECA.
The design of the stent and its hemodynamic properties
could inﬂuence patency of the ECA. In our previous retro-
spective analysis we could not show a relationship between
the type of stent that was used and the progression of
stenosis.10 In this study the number of patients and the
large variety of different stents used in this study precluded
accurate analysis of the relationship between stent type
and progression of stenosis.
In surgery, eversion endarterectomy of the ECA might
preserve the collateral pathway in case of a recurrent ste-
nosis of the ICA and some studies recommend this
approach.20,21 Other authors concluded that endarterec-
tomy of the ECA during CEA does not result in signiﬁcantly
lower ECA stenosis or occlusion rates during follow-up.7,22,23
By eversion endarterectomy any narrowing of the lumen of
the ECA is (partially) corrected. Clearing the origin of the
ECA from atherosclerotic plaque has been shown to be of
value as residual plaque in the ECA may serve as a source of
emboli into the internal carotid circulation.18
In our study, despite ECA endarterectomy, approximately
30% of the patients had a PSV exceeding 125 cm/s on DUS
at 30 days after surgery. Moreover, during further follow-up,
approximately 46% of patients with a preoperative PSVECA
<125 cm/s showed progression of PSVECA to 125 cm/s or
more after 2 years. A possible explanation could be neo-
intimal hyperplasia or thrombus forming at the site of the
eversion endarterectomy, as well as residual plaque that
was not resected during (semi-blind) endarterectomy of the
ECA. The peak systolic velocity may also be affected by the
exact segment of the ECA that is analyzed. If only the
proximal segment is analyzed, the PSV would probably be
lower following blind endarterectomy. In our vascular lab-
oratory we analyze the proximal and the mid-ECA and the
highest PSV within the artery was reported. This approach
could cause a higher overall rate of ECA stenosis.
For grading ECA stenosis by DUS, some authors found the
peak systolic ﬂow ratio ECA/CCA to be superior than PSV or
end-diastolic velocities (EDV, ECA).24 In addition, ICA ste-
nosis was often accompanied by a false increase in ECA ﬂowratio in the normal ECA, and it was assumed that the same
applied to the stenotic ECA. This would indicate over-
estimation of the ECA stenosis severity with DUS before
treatment of high-grade ICA stenoses, followed by a
apparent drop in number of ECA stenoses of 50% or greater
at day 1 after treatment. Furthermore, when endarterec-
tomy relieves bifurcation stenosis, CCA blood ﬂow is
redistributed preferentially to the ICA at the expense of ECA
ﬂow, consistent with a change in the relative resistances of
the two vessels resulting from operative reconstruction.25
Resistance in the ICA is relieved and therefore ﬂow in-
creases through the ICA. Because of the increase in ﬂow in
the ICA, the ECA ﬂow will consequently decrease. Another
group also found this same reduction in ECA blood ﬂow
(55% to 44%) after CEA because of an increase in ﬂow in the
ICA.3 This redistribution of ﬂow also occurs following CAS
and therefore did not affect our analysis.Study limitations
A limitation of this study is the difﬁculty in accurately
grading the degree of anatomical stenosis of the ECA based
on duplex ﬂow velocities. There is still no consensus on
whether ﬂow velocities in an ECA of which the oriﬁce has
been covered by a stent correspond to ﬂow velocities in an
ECA following endarterectomy. Due to the lack of well-
deﬁned and generally accepted duplex criteria for grading
stenosis in the ECA, especially in stented arteries, we used
the same predeﬁned cut-off point of 125 cm/s to compare
both procedures. This cut-off is arbitrary but in our opinion
can be used to study the pattern of changes in blood ﬂow
velocities following carotid revascularization. Whether this
increase in PSV reﬂects a true increase in degree of stenosis
can only be stated when validated duplex criteria in the ECA
are deﬁned. Different stent types could also result in
different hemodynamic properties and therefore their in-
direct effect on ﬂow velocities and branch patency remains
speculative. Our sample size was too small and the het-
erogeneity of the type of stents used too large to accurately
analyze the relationship between stent type and progres-
sion of stenosis. Smoking habits could inﬂuence restenosis
rates and the lack of post-interventional data on smoking is
a limitation of this study.
Both procedures were performed in a single institution
and therefore reﬂect our own revascularization techniques.
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Within this randomized study, the increase in blood ﬂow
velocities in the ECA was signiﬁcantly higher following CAS
than CEA during a follow-up of at least 2 years. This increase
in peak systolic velocity, however, did not lead to a higher
occlusion rate of the ipsilateral ECA. Besides plaque protru-
sion, neo-intimal hyperplasia at the origo of the ECA could be
an explanation for the relative increase in blood ﬂow ve-
locities in the ECA following CAS. Two years after revascu-
larization, CAS is not inferior to CEA in preserving the ECA as
a potential collateral pathway for cerebral blood supply.FUNDING
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